CRIS Current Research Information System

BELLUTI, FEDERICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.742
AS - Asia 6.214
EU - Europa 4.233
AF - Africa 365
SA - Sud America 285
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 3
Totale 17.854
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.637
VN - Vietnam 1.704
SG - Singapore 1.610
CN - Cina 1.569
IT - Italia 897
GB - Regno Unito 888
DE - Germania 588
HK - Hong Kong 373
SE - Svezia 358
IN - India 281
FR - Francia 251
UA - Ucraina 241
RU - Federazione Russa 233
BR - Brasile 183
NL - Olanda 160
IE - Irlanda 138
JP - Giappone 124
CI - Costa d'Avorio 116
KR - Corea 113
FI - Finlandia 103
ZA - Sudafrica 99
JO - Giordania 97
CA - Canada 75
TG - Togo 70
BG - Bulgaria 64
EE - Estonia 61
PH - Filippine 47
AR - Argentina 46
ID - Indonesia 44
ES - Italia 39
BD - Bangladesh 35
PL - Polonia 35
CH - Svizzera 34
SC - Seychelles 32
IR - Iran 30
TR - Turchia 30
PK - Pakistan 28
TH - Thailandia 28
IQ - Iraq 25
AT - Austria 24
BE - Belgio 20
GR - Grecia 19
MX - Messico 19
CZ - Repubblica Ceca 18
EC - Ecuador 17
HR - Croazia 16
MY - Malesia 13
CO - Colombia 11
EG - Egitto 11
NG - Nigeria 11
SA - Arabia Saudita 11
TW - Taiwan 11
LT - Lituania 9
AU - Australia 8
LB - Libano 8
VE - Venezuela 8
CL - Cile 7
KE - Kenya 7
KZ - Kazakistan 7
HU - Ungheria 6
PT - Portogallo 6
DZ - Algeria 5
PS - Palestinian Territory 5
PY - Paraguay 5
RO - Romania 5
TN - Tunisia 5
AL - Albania 4
GT - Guatemala 4
MD - Moldavia 4
AE - Emirati Arabi Uniti 3
BO - Bolivia 3
BY - Bielorussia 3
ET - Etiopia 3
NZ - Nuova Zelanda 3
OM - Oman 3
RS - Serbia 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
AZ - Azerbaigian 2
HN - Honduras 2
KW - Kuwait 2
LK - Sri Lanka 2
MA - Marocco 2
NO - Norvegia 2
NP - Nepal 2
PA - Panama 2
PE - Perù 2
UY - Uruguay 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
GH - Ghana 1
GI - Gibilterra 1
GY - Guiana 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
Totale 17.849
Salva come PNG Salva come JPEG
Città #
Singapore 1.104
Southend 755
Ashburn 682
Fairfield 583
Chandler 560
Ho Chi Minh City 363
Santa Clara 362
Hong Kong 355
San Jose 345
Hanoi 327
Bologna 318
Woodbridge 308
Seattle 278
Wilmington 274
Houston 259
Hefei 237
Dong Ket 227
Cambridge 218
Ann Arbor 193
Princeton 188
Beijing 186
Jacksonville 153
Dublin 138
Boardman 132
Abidjan 116
New York 114
Tokyo 101
Council Bluffs 100
Seoul 97
Amman 96
Los Angeles 88
Nanjing 85
Helsinki 82
Westminster 81
Lauterbourg 80
Dallas 71
Lomé 70
Padova 68
Berlin 64
Sofia 64
Buffalo 56
Munich 54
Jinan 52
Bremen 50
Da Nang 50
San Diego 45
Shenyang 45
Saint Petersburg 43
Milan 37
Redondo Beach 37
Frankfurt am Main 35
Guangzhou 35
Redmond 35
Haiphong 34
Nanchang 32
Mülheim 31
Tianjin 31
Hebei 30
Jakarta 30
Shanghai 29
Bern 28
Orem 26
Quận Bình Thạnh 26
Bengaluru 24
Changsha 24
Dearborn 24
Biên Hòa 23
Jiaxing 23
Warsaw 23
Zhengzhou 23
Nuremberg 22
São Paulo 22
Hải Dương 21
Johannesburg 21
Medford 21
Montreal 20
Olalla 20
Brussels 19
London 19
Des Moines 18
Mahé 18
Chicago 17
Phoenix 17
Redwood City 17
Can Tho 16
Sant Cugat del Vallès 16
Toronto 16
Venezia 16
Atlanta 15
Shenzhen 15
Thái Nguyên 15
Boydton 14
Falkenstein 14
Mountain View 14
Haikou 13
Kunming 13
Baghdad 12
Bangkok 12
Brooklyn 12
Hangzhou 12
Totale 11.454
Salva come PNG Salva come JPEG
Nome #
1,4-dihydropyridine derivatives as calcium channel modulators: the role of 3-methoxy-flavone moiety 348
Discovery of novel benzofuran-based compounds with neuroprotective and immunomodulatory properties for Alzheimer's disease treatment 325
Multitarget Strategy to Address Alzheimer's Disease: Design, Synthesis, Biological Evaluation, and Computational Studies of Coumarin-Based Derivatives 287
Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation. 250
Structure-Activity Relationships and Binding Mode in the Human Acetylcholinesterase Active Site of Pseudo-Irreversible Inhibitors Related to Xanthostigmine 244
Progettazione e sintesi di derivati benzofuranici per la malattia di Alzheimer 236
Chitosan nanoparticles for lipophilic anticancer drug delivery: Development, characterization and in vitro studies on HT29 cancer cells 233
Design, synthesis and biological profile of new inhibitors of multidrug resistance associated proteins carrying a polycyclic scaffold 218
Analogues of the dual acetylcholinesterase inhibitor AP2238: synthesis and SAR 216
Benzophenones as xanthone-open model CYP11B1 inhibitors potentially useful for promoting wound healing 215
Targeting neuronal calcium channels and GSK3β for Alzheimer's disease with naturally-inspired Diels-Alder adducts 214
Versatility of the Curcumin Scaffold: Discovery of Potent and Balanced Dual BACE-1 and GSK-3β Inhibitors 214
Identification of chalcone-based antileishmanial agents targeting trypanothione reductase 210
Fatty Acid Amide Hydrolase (FAAH), Acetylcholinesterase (AChE), and Butyrylcholinesterase (BuChE): Networked Targets for the Development of Carbamates as Potential Anti-Alzheimer's Disease Agents 210
Exploiting the chalcone scaffold to develop multifunctional agents for Alzheimer’s disease 209
2-Arylbenzofuran-based molecules as multipotent Alzheimer's disease modifying agents 206
Identification of a new tamoxifen-xanthene hybrid as pro-apoptotic anticancer agent 203
Development of a Focused Library of Triazole-Linked Privileged-Structure-Based Conjugates Leading to the Discovery of Novel Phenotypic Hits against Protozoan Parasitic Infections 202
Targeting the multifaceted neurotoxicity of Alzheimer's disease by tailored functionalisation of the curcumin scaffold 200
SAR and binding mode at the h-AChE active site of pseudo-irreversible inhibitors related to Xanthostigmine 199
Balanced dual acting compounds targeting aromatase and estrogen receptor α as an emerging therapeutic opportunity to counteract estrogen responsive breast cancer 199
Extensive SAR and computational studies of 3-{4-[(benzylmethylamino)methyl]phenyl}-6,7-dimethoxy-2H-2-chromenone (AP2238) derivatives. 197
Benzophenone-based derivatives: A novel series of potent and selective dual inhibitors of acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation 196
Naturally inspired molecules as multifunctional agents for Alzheimer's disease treatment 195
Natural-like Chalcones with Antitumor Activity on Human MG63 Osteosarcoma Cells 194
Cardiovascular profile of xanthone-based 1,4 dihydropyridines bearing a lidoflazine pharmacophore fragment 193
Interplay Between Endocannabinoid System and Neurodegeneration: Focus on Polypharmacology 189
Curcumin-1,2,3-triazole conjugation for targeting the cancer apoptosis machinery. 189
Complementary medicinal chemistry-driven strategies toward new antitrypanosomal and antileishmanial lead drug candidates 187
CHOLINESTERASE INHIBITORS: SAR AND ENZYME INHIBITORY ACTIVITY OF 3-[omega-(BENZYLMETHYLAMINO)ALKOXY]XANTHEN-9-ONES 186
Novel Curcumin-Diethyl Fumarate Hybrid as a Dualistic GSK-3β Inhibitor/Nrf2 Inducer for the Treatment of Parkinson's Disease 186
Enantioselective nonsteroidal aromatase inhibitors identified through a multidisciplinary medicinal chemistry approach 179
Potent inhibition of human phosphodiesterase-5 by icariin derivatives 177
Potent inhibition of human phosphodiesterase-5 by icariin derivatives in an enzyme assay 174
Chitosan nanoparticles for curcumin delivery: development, characterization and in-vitro studies on cancer cells 174
Polycyclic maleimide-based derivatives as first dual modulators of neuronal calcium channels and GSK-3β for Alzheimer's disease treatment 173
New Coumarin derivatives as cholinergic and cannabinoid system modulators 170
Lead optimization providing a series of flavone derivatives as potent nonsteroidal inhibitors of the cytochrome P450 aromatase enzyme 168
Multifaceted activity of polyciclic MDR revertant agents in drug-resistant leukemic cells: Role of the spacer 168
Emerging targets in neurodegeneration: new opportunities for Alzheimer's disease treatment? 167
Single-digit nanomolar inhibitors lock the aromatase active site via a dualsteric targeting strategy 166
Nonsteroidal Aromatase inhibitors: synthesis and evaluation of new flavone derivatives 166
Derivati a struttura benzofenonica come inibitori dell'acetilcolinesterasi 164
Multitarget Ligands in the Search for Novel Lead Candidates against Trypanosoma and Leishmania 164
Homopterocarpanes as bridged triarylethylene analogues: synthesis and antagonistic effects in human MCF-7 breast cancer cells 163
Fluorinated benzophenone derivatives: balanced multipotent agents for Alzheimer's disease 162
Design, synthesis, and evaluation of benzophenone derivatives as novel acetylcholinesterase inhibitors 161
Conjugation of Quinones with Natural Polyamines: Toward an Expanded Antitrypanosomatid Profile 161
Reconsidering Aromatase for Breast Cancer Treatment: New Roles for an Old Target 160
Imidazolylmethylbenzophenones as highly potent aromatase inhibitors. 158
Multitarget Compounds for Bipolar Disorder: From Rational Design to Preliminary Pharmacokinetic Evaluation 158
Multi-target-directed coumarin derivatives: hAChE and BAC1 inhibitors as potential anti-Alzheimer compounds 155
Phenolic 1,3-diketones attenuate lipopolysaccharide-induced inflammatory response by an alternative magnesium-mediated mechanism 152
New derivatives of xanthenone-4-acetic acid: synthesis, pharmacological profile and effect on TNF-alpha and NO production by human immune cells 151
Improved eradication efficacy of a combination of newly identified antimicrobial agents in C. albicans and S. aureus mixed-species biofilm 151
Naturally Inspired Coumarin Derivatives in Alzheimer’s Disease Drug Discovery: Latest Advances and Current Challenges 150
In vitro studies of flavon-8-acetic acid analogues 150
Studies on cytostatic and cytotoxic activity of new flavopiridol analogues 150
Functionalization of the chalcone scaffold for the discovery of novel lead compounds targeting fungal infections 149
In vitro biological activity of new analogues of flavon-8-acetic acid 148
Benzophenone derivatives as Inhibitors of Acetylcholinesterase 148
Switching from Aromatase Inhibitors to Dual Targeting Flavonoid-Based Compounds for Breast Cancer Treatment 147
Hybrid drugs for Alzheimer's disease: new indanone derivatives bearing a pharmacophoric fragment of AP2238 147
Toward the Development of Dual-Targeted Glyceraldehyde-3-phosphate Dehydrogenase/Trypanothione Reductase Inhibitors againstTrypanosoma bruceiandTrypanosoma cruzi 146
From AChE to BACE1 inhibitors: The role of the amine on the indanone scaffold 145
Multi-target strategy to address Alzheimer’s disease: Design, synthesis and biological evaluation of new tacrine-based dimers 145
Design, Synthesis, and Biological and Crystallographic Evaluation of Novel Inhibitors ofPlasmodium falciparumEnoyl-ACP-reductase (PfFabI) 144
Flavonoid-inspired vascular disrupting agents: Exploring flavone-8-acetic acid and derivatives in the new century 144
High-throughput screening of beta-secretase inhibitors by multiwell FRET assay 143
New potent P-glycoprotein inhibitors carrying a polycyclic scaffold 143
Polycyclic Maleimide-based Scaffold as New Privileged Structure for Navigating the Cannabinoid System Opportunities 142
Curcumin derivatives as beta-secretase (BACE1) inhibitors. 140
Targeting the Bacterial Membrane with a New Polycyclic Privileged Structure: A Powerful Tool To Face Staphylococcus aureus Infections 137
Design of Multifunctional Compounds for Cardiovascular Disease: From Natural Scaffolds to “Classical” Multitarget Approach 135
Novel highly potent and selective nonsteroidal aromatase inhibitors: synthesis, biological evaluation and structure-activity relationships investigation 133
New potent inhibitors of cytochrome P450 aromatase 131
Modulation of Amyloid β-induced Microglia Activation and Neuronal Cell Death by Curcumin and Analogues 127
Imidazolylmethylxanthones as potent inhibitors of cytochrome P450 aromatase 127
Hybrid-Based Multi-Target Ligands for the Treatment of Alzheimer's Disease 125
Chalcone-based carbamates for Alzheimer's disease treatment 125
null 123
The first dual ChE/FAAH inhibitors: new perspectives for Alzheimer's disease? 122
Nonsteroidal aromatase inhibitors for the treatment of breast cancer: an update. 121
Mono- or di-fluorinated analogues of Flavone-8-acetic acid: synthesis and in vitro biological activity 121
Modulation of Cytochromes P450 with Xanthone-Based Molecules: From Aromatase to Aldosterone Synthase and Steroid 11β-Hydroxylase Inhibition 119
In vitro methods for characterizing new multi-potent compounds for Alzheimer’s disease 119
Coumarin derivatives as potential antitumor agents: Growth inhibition, apoptosis induction and multidrug resistance reverting activity 118
null 118
Tackling Alzheimer's Disease with Existing Drugs:A Promising Strategy for Bypassing Obstacles 116
Hitting drug-resistant malaria infection with triazole-linked flavonoid–chloroquine hybrid compounds 111
Small-molecule inhibitors/modulators of amyloid-β peptide aggregation and toxicity for the treatment of Alzheimer's disease: a patent review (2010 – 2012) 110
Prenylated Curcumin Analogues as Multipotent Tools to Tackle Alzheimer's Disease 107
null 105
null 103
Chromone-based small molecules for multistep shutdown of arachidonate pathway: Simultaneous inhibition of COX-2, 15-LOX and mPGES-1 enzymes 101
Quinone-Amino Acid Conjugates Targeting Leishmania Amino Acid Transporters 97
Extended Antimicrobial Profile of Chromone–Butenafine Hybrids 96
Recent progress on curcumin-based therapeutics: a patent review (2012-2016). Part I: Curcumin 88
Recent progress on curcumin-based therapeutics: a patent review (2012-2016). Part II: curcumin derivatives in cancer and neurodegeneration 86
null 83
Totale 16.377
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.549
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.549
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021591 0 0 0 0 0 0 0 0 0 70 90 431
2021/20221.774 164 47 107 90 150 92 48 181 94 137 341 323
2022/20232.331 211 273 112 275 187 180 65 148 469 70 164 177
2023/2024745 40 99 38 89 54 212 47 42 14 35 38 37
2024/20252.604 103 366 264 135 535 128 220 76 53 184 142 398
2025/20265.963 727 548 564 456 678 335 603 308 1.294 450 0 0
Totale 18.261